U.S. District Judge Karin J. Immergut has halted President Donald Trump’s proposed plan to send federal troops to Portland. The ruling, delivered on Saturday, places a significant legal obstacle in the administration’s efforts in Oregon.
A coalition of unions and other groups has filed a lawsuit against the Trump administration’s newly imposed $100,000 H-1B visa fee. Claiming the charge is both “extortionate” and “draconian,” they aim to block what they believe will harm workers and organizations seeking skilled foreign labor.
In an unusual move, the Trump administration is calling on Army Reserve and National Guard members to serve as temporary immigration judges. While the detailed rationale remains behind a paywall, the shift indicates a notable expansion of military roles in domestic legal matters.
A new ruling from the U.S. Supreme Court allows the Trump administration to revoke deportation protections for Venezuelans, affecting potentially hundreds of thousands of people. Multiple outlets, including The New York Times and CNN, confirm this decision removes key legal shields previously granted to Venezuelan migrants.
The Trump administration plans to end $400 million in energy grants that bolster Oregon’s clean technology sector and workforce development programs. The cancellations are set to halt major transmission upgrades and energy-efficiency projects across the state, raising concerns among local officials and industry leaders.
The U.S. Food and Drug Administration, operating under Donald Trump’s presidency, approved a new generic abortion pill. This decision arrives as abortion medications face increased scrutiny nationwide, highlighting the ongoing debate over reproductive rights.
Nine leading universities, including Brown and MIT, have received a 10-point “compact” from the White House linking federal support to conservative ideas. The proposal promises “substantial and meaningful federal grants” but has triggered free speech concerns among educators and policymakers.
Pfizer made headlines by forging a drug pricing agreement with the Trump administration, surprising many in the pharmaceutical industry. The move exposed rifts within Big Pharma, as other companies were left scrambling to respond.
In a significant blow to New York City’s infrastructure plans, the Trump administration has pulled $18 billion in federal funding. This move directly affects two major projects, most notably the Second Avenue Subway expansion, sparking concerns about the future of the city’s transit development.
President Trump announced his administration is on the verge of finalizing a deal with Harvard University to resolve a dispute over funding cuts and governance changes. The pending agreement seeks to ease tensions between the White House and one of America’s most prominent Ivy League institutions.
